◉Tech Investing RadarBY MARC WINN
← All themes
ComputingWatching

Fault-tolerant quantum computing

Quantum computers could solve certain problems that are difficult for conventional machines. I’m watching the gap between scientific progress and useful work someone will pay for.

What I’m watching: Specialist discussion moves towards a specific useful application and new participants begin taking it seriously.

What could change the picture?
What the evidence says
A company’s reported platform revenue gives some commercial context. It combines several activities, so it cannot establish useful fault-tolerant computing or the economics of a customer’s quantum workload.
Early recognition to watch
Specialist discussion moves towards a specific useful application and new participants begin taking it seriously
Commercial confirmation
A paying customer repeats a useful workload against a classical baseline. Next evidence: Find independently reproducible workloads, logical error rates, customer contracts and runway.
What people used to expect
Working expectation to monitor: Cost per verified useful computational result remains constrained by Logical qubits, error correction and useful algorithms. This is a research hypothesis, not measured consensus.
What may be changing
Potential change to investigate: A paying customer repeats a useful workload against a classical baseline. Current evidence does not yet demonstrate a broad change in belief.
Who could benefit
Candidate how a business could benefit in Fault-tolerant quantum computing: Test control electronics, software and hardware architectures without assuming one winner before fault tolerance.
Timing
Catalyst dependent; no supported repricing date yet
What the market may already expect
Current price, expectations and investable exposure have not been assessed in this packet. Existing source evidence is not a buy or sell cue.
The strongest reason to be cautious
More qubits or a specialised benchmark may not produce a commercially useful result.
What would change the view
Keep experimental progress speculative until useful advantage and a financed path to delivery are demonstrated.
Detailed research notes

Dated research baseline, imported today rather than a new event: IonQ reports $80.1m Q2 2026 revenue across its quantum platform. (2026-08-05). Includes multiple product lines and acquisition effects; not fault-tolerant compute revenue alone or demonstrated economic advantage. The quarter excludes the subsequent SkyWater acquisition. Company reports are not independent validation. Revenue classifications and contract backlog cannot stand in for funded compute demand or useful task economics. (2026-08-05). Organic revenue uses an acquisition cut-off; not pure quantum advantage. SkyWater consolidated after quarter end, while commercial relationship costs were already included. Issuer definitions, not customer ROI.

Follow the evidence

IonQ Superion announcement: IonQ reports Superion prototype progress and orders, with delivery in2027. ↗Published 8 Sept 2026

IonQ reports Superion prototype progress and orders, with delivery in 2027. Limitation: Not accepted customer operation, fault-tolerant useful output or matched classical-workload advantage. Roadmap and issuer assertions remain prospective; no current unit cost inferred. Existing research checked 2026-10-12.

IonQ SEC-filed release: IonQ reports $80.1m Q2 2026 revenue across its quantum platform. ↗Published 5 Aug 2026

IonQ reports $80.1m Q2 2026 revenue across its quantum platform. Limitation: Includes multiple product lines and acquisition effects; not fault-tolerant compute revenue alone or demonstrated economic advantage. The quarter excludes the subsequent SkyWater acquisition. Company reports are not independent validation. Existing research checked 2026-10-04. Revenue classifications and contract backlog cannot stand in for funded compute demand or useful task economics. Limitation: Organic revenue uses an acquisition cut-off; not pure quantum advantage. SkyWater consolidated after quarter end, while commercial relationship costs were already included. Issuer definitions, not customer ROI. Existing research checked 2026-10-12.

low confidence · Assessment 17 Oct 2026. Evidence dates are shown separately.